JT
TGTX icon

Jupiter Topco’s TG Therapeutics TGTX Stock Holding History

Jupiter Topco’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
+96,823
New +$3.96M ﹤0.01% 1028

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Jupiter Topco's TGTX Position: Q2 2026 in Review

Jupiter Topco opened a new position in TG Therapeutics (TGTX) in Q2 2026: 96,823 shares worth $5.32M. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings.

405 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Jupiter Topco held 96,823 shares of TG Therapeutics worth $5.32M as of Q2 2026.
  • TG Therapeutics was a new Jupiter Topco position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1028 holding.
  • 405 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.